Tamoxifen treatment has been linked to an excess risk of nonalcoholic steatohepatitis, which is characterized by inflammation and fatty deposits in the liver. Bruno and colleagues have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results